The research led by the candidate will utilize patient-derived tissues, high-content imaging, organoid-based 3D bioprinting systems, high-throughput drug screening, genome-editing tools, and in vivo tumorigenesis models to evaluate the impact of small molecules on epigenetic regulation mechanisms essential to neoplastic stemness. The candidate will also work with bulk, spatial, and single-cell genomic analyses, spectral flow cytometry, and single-cell proteomics.

​

The position is for motivated PhD or MD/PhD holder, who graduated from a highly recognized academic program, aiming to develop an independent research career.

​

• A strong background in cancer and/or stem cell biology is required. Advanced skills in cellular imaging, molecular biology, flow cytometry, mammalian cell culture, in vivo models, and genomic data analysis are highly desirable. Priority will be given to candidates with demonstrated computational biology knowledge and proficiency.

• Ability to work independently, show self-initiative and attention to detail, and motivation to explore new techniques and concepts are essential.

• Publication of relevant research work in recognized scientific journals is an asset.

• Outstanding written and oral communicational skills, team spirit, and adherence to highest ethical principles when collecting experimental data and working with laboratory animals are necessary.